In honor of cervical cancer awareness month, Lauren Bollinger, MD, a gynecologic oncologist with Minnesota Oncology, recently authored an article for Targeted Oncology on cervical cancer research and treatment.
Dr. Bollinger discusses how the increase in research in the field of cervical cancer is driving the progress of treatment.
“The cervical cancer landscape is dramatically changing for the better as new drug therapies, including antibody drug conjugates and immunotherapies, come into play vs traditional chemotherapy. Taking a closer look at what is driving all this excitement is worthwhile, as these developments will likely impact the standard of care for patients with cervical cancer for years to come.”
Read the article: Cervical Cancer Awareness Month: Dramatic Increase in Cervical Cancer Research is Driving Treatment Progress
Share
Categories
Tags
Recent Posts
Biomarkers are proteins, hormones, or pieces of DNA that can be released by cancer cells or by your body in response to cancer.
A lung cancer guide to help in gathering the information you need to make informed choices for your treatment journey.
Lung cancer is the leading cause of all cancer deaths in the United States. Research has found that high risk people who get low-dose CT scans of the chest had a 20% lower chance of dying from lung cancer than those who got only chest X-rays.